Michał Walczak is a Ph.D student in Institute of Human Genetics PAS since August 2015. His research is focused on pharmacogenetic studies. He is currently analyzing the genetic background which is responsible for different patients reaction for treatment. His field of interest include genes involved in reaction for biological, analgesics and cannabinoid drugs. The research is based on high throughput DNA next generation sequencing methods.
dr n. med. Michał Walczak
Publications
Polymorphic Variants of Genes Encoding Angiogenesis-Related Factors in Infertile Women with Recurrent Implantation Failure.
Mrozikiewicz AE, Kurzawińska G, Ożarowski M, Walczak M, Ożegowska K, Jędrzejczak P
Int J Mol Sci, 2023, 24, 4267; doi: 10.3390/ijms24054267IF-6.208 MNiSW-140
Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease.
Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M
Toxic, 2022, 10 (4), 151, 19 stron, doi/10.3390/toxics1004015IF-4,146 MNiSW-70
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
Lykowska-Szuber L, Walczak M, Skrzypczak-Zielińska M, Suszynska-Zajczyk J, Stawczyk-Eder K, Waszak K, Eder P, Wozniak A, Krela-Kaźmierczak I, Słomski R and Dobrowolska A
Front Immunol., 2021 09 March, 12, art no 615539, 12 stron, doi: 10. 3389/fimmu.2021.615539IF-5,085 MNiSW-140
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
Walczak M, Łykowska-Szuber M, Plucińska M, Stawczyk-Eder K, Zakerska-Banaszak O, Eder P, Krela-Kaźmierczak I, Michalak M, Żywicki M, Karłowski WM, Szalata M, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Front. Pharmacol., 2020 Aug 14, 11, art 1207,12 str| ,https://doi.org/10.3389/fphar.2020.01207IF-4,225 MNiSW-100
Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs.
Walczak M, Skrzypczak-Zielińska M, Plucinska M, Zakerska-Banaszak O, Marszałek D, Łykowska-Szuber L, Stawczyk-Eder K, Dobrowolska A, Słomski R;
Pharmacogenomics J., 2019, 19 (4): 358-367, Epub 2018 Oct 8. doi: 10.1038/s41397-018-0058-9.
Bitter taste of Brassica vegetables: the role of genetic factors, receptors, isothiocyanates, glucosinolates and flavor context.
Wieczorek MN, Walczak M, Skrzypczak-Zielińska M, Jeleń HH;
Crit Rev Food Sc Nutr, 2018, 58 (18): 3130-40.
Pharmacogenetics of cannabinoids.
Hryhorowicz S, Walczak M, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M;
Eur J Drug Metab Pharmacokinet., 2018, 43 (1): 1-12, Epub 2017 May 22.
Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.
Zakerska-Banaszak O, Skrzypczak-Zielińska M, Tamowicz B, Mikstacki A, Walczak M, Prendecki M, Doroszewska J, Pollak A, Lechowicz U, Oldak M, Huminska-Lisowska K, Molinska-Glura M, Szalata M, Słomski R;
Scientific Report, 2017, Nov 13; 7(1):15399. doi: 10.1038/s41598-017-15657-2.
A simple method for TPMT and ITPA genotyping using multiplex HRMA for patients treated with thiopurine drugs.
Skrzypczak-Zielińska M, Boruń P, Bartkowiak-Kaczmarek A, Zakerska-Banaszak O, Walczak M, Dobrowolska A, Kurzawski M, Waszak M, Lipiński D, Pławski A, Słomski R; Szalata M, Słomski R;
Mol Diagn Ther, 2016, 20, 5: 493-499.
All publications
Events
2015 Where:
Glasgow
